Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

84.23 -1.26 (-1.47%)
Streaming Delayed Price Updated: 3:01 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares U.S. Pharmaceutical ETF

< Previous 1 2 3 Next >
News headline image
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares ↗
Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase. 
Via Benzinga
Topics ETFs
News headline image
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' ↗
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency. 
Via Benzinga
Topics Government
News headline image
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr. ↗
Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease. 
Via Benzinga
Topics Government
News headline image
A Look At Pharma ETFs Post Q1 Earnings ↗
Pharma ETFs have delivered mixed performances over the past month. 
Via Talk Markets
Topics ETFs
News headline image
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook ↗
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
Via Talk Markets
Topics ETFs
News headline image
3 Sector ETFs That Beat The Market Last Week ↗
Here are three ETFs from different sectors that were in green last week. 
Via Talk Markets
Topics ETFs
News headline image
US Pharmaceuticals: A Bifurcated Market ↗
The US pharmaceutical industry faces two important goals that conflict with each other. 
Via Talk Markets
News headline image
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market ↗
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
News headline image
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors ↗
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher. 
Via Benzinga
News headline image
A Look At Pharma ETFs After Q4 Earnings ↗
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. 
Via Talk Markets
Topics ETFs
News headline image
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge ↗
Bank of America lists 10 market surprises; warns investors to be wary of the bond market's dovish position compared to the Fed. 
Via Benzinga
Topics Bonds
News headline image
3 Beaten-Down ETFs To Buy For A Turnaround In 2024 ↗
Following three consecutive monthly losses since the COVID pandemic began in March 2020, Wall Street recorded a robust recovery starting in November. we have highlighted ETFs from different zones that... 
Via Talk Markets
Topics ETFs
News headline image
5 Secret Santa ETFs That Might Surprise You This Christmas ↗
Wall Street has been sizzling hot this holiday season. This is likely to continue, given that the Santa Claus rally is on the way. Against such a backdrop, there are some hidden gems which could... 
Via Talk Markets
Topics ETFs
News headline image
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest ↗
In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) raised their voices by calling out sick or walking out... 
Via Benzinga
News headline image
5 Sector ETFs That Outperformed in Turbulent August ↗
Wall Street has lost momentum since the start of August, triggered by the series of bank downgrades and fears of higher rates for a longer-than-expected period. 
Via Talk Markets
Topics ETFs
News headline image
Q2 Earnings & Market Sell-Off Impact: 5 Must-See ETF Charts ↗
While longer-than-expected rate worries and banking concerns led to feeble trading in recent weeks, a few equity ETFs rose or saw a modest decline over the past month. 
Via Talk Markets
Topics ETFs
News headline image
Pharma ETFs in Focus Post Q2 Earnings ↗
Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth. 
Via Talk Markets
Topics ETFs
News headline image
3 Biotech Stocks to Sell in June Before They Crash and Burn ↗
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them. 
Via InvestorPlace
News headline image
Pharma ETFs Gain Post Q1 Earnings ↗
Pharma ETFs have been in the green over the past month. 
Via Talk Markets
News headline image
A Look At Pharma ETFs Post Q4 Earnings ↗
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month. 
Via Talk Markets
News headline image
4 Sector ETFs To Watch Ahead Of Mid-Election Results ↗
Some market analysts are signaling that a political gridlock by Republicans may be a positive for Wall Street and the U.S. economy. 
Via Talk Markets
News headline image
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority? ↗
The 2022 election was held on Tuesday, Nov. 8. No decision has been made as to who won many of the key battles, including several pivotal seats in the U.S. House of Representatives and U.S. Senate. 
Via Benzinga
News headline image
Pharma ETFs In Focus Post Q3 Earnings ↗
Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month. 
Via Talk Markets
News headline image
ETF Mid-Year Outlook & Investing Strategies ↗
While positioning the portfolio for the second half investors should focus on three themes: 1) embracing volatility, 2) living with inflation, and 3) the long-term impacts of shortages. 
Via Talk Markets
News headline image
Wave of Solid Q3 Earnings Push Pharma ETFs Higher ↗
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month. 
Via Talk Markets
News headline image
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data ↗
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations. 
Via Talk Markets
News headline image
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval? ↗
Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine. 
Via Talk Markets
News headline image
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer ↗
The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. 
Via Talk Markets
News headline image
Tuesday Talk: Slip Sliding Sideways ↗
With the Middle East seemingly going to Hell in a proverbial handbasket the markets seem to be slip sliding, not away (as the Paul Simon song would have it) sideways as it were. 
Via Talk Markets
News headline image
5 Sector ETFs That Survived Last Week's Turmoil ↗
Here are five sector ETFs that performed well last week and survived the broad market rout. 
Via Talk Markets
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.